#USA #New York #SueWallSt #BYAH #Park Ha Biological

Class Action Notification for BYAH Investors

Institutional investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) should be alerted to a significant class action lawsuit filed on behalf of shareholders who acquired company securities during the specified period from December 27, 2024, to July 8, 2025. This lawsuit follows a dramatic plunge in the company’s stock price, which led to a loss exceeding $1 billion in market capitalization. On July 8, 2025, BYAH’s shares collapsed approximately 93%, plummeting to $2.99 from a previous close of $41.01.

Background of the Lawsuit

The class action claims that the company, Park Ha Biological Technology, failed to disclose essential information regarding its stock's trading activity, including the existence of a coordinated promotional scheme designed to inflate stock prices artificially. The lawsuit asserts that the public offerings were structured in a way that allowed the company's public float to be less than 5%, making shares susceptible to market manipulation. This information, or lack thereof, directly impacted the investors' valuation assumptions and liquidity considerations.

Joseph E. Levi, Esq., a representative from the law firm involved, indicated the importance of institutional investors reviewing their risk management and valuation strategies in light of the alleged omissions. He stressed that fiduciaries managing BYAH investments should assess how these disclosures affected their holdings and liquidity.

Responsibilities for Institutions

It is crucial for institutional investors and fiduciaries, including pension funds and asset managers, to evaluate claims that could be recoverable under securities litigation. The deadline for filing as a lead plaintiff is September 28, 2026, making it vital for those interested to gather necessary brokerage records, including purchase dates, quantity of shares, and prices.

The process to take action is straightforward. Interested parties can contact SueWallSt, a service brand of Levi Korsinsky LLP, for a no-cost assessment of their potential losses. They can send inquiries regarding the lawsuit to the specified email or phone number, highlighting there are no upfront costs involved in engaging with this firm. Notably, investors who sold their BYAH securities at a loss may still qualify based on specific purchase dates within the class period.

Summary of Claims

The lawsuit asserts that Park Ha Biological Technology's financial performance was not reflective of its inflated market capitalization, as substantial doubts remained regarding its actual revenue generation capabilities. Reports indicated that the company's franchise operations generated minimal revenue against a claimed market cap of over $1 billion shortly after its stock price soared beyond reasonable business metrics.

The Importance of Acting Quickly

As class action lawsuits can take significant time and resources to navigate, it's vital for affected investors to take prompt action. Institutions that remain inactive before the cutoff may still benefit from possible future recoveries as absent class members; however, that participation lacks the direct oversight and engagement that comes with lead plaintiff status. Tracking custodial and transaction records will be essential for supporting any asserted claims.

By understanding the framework of this class action, and the ramifications on their investments, Park Ha’s shareholders can begin to determine their next steps tailored to their investment strategies. Engaging professional legal counsel early in the process not only provides clarity but ensures adherence to strict filing timelines associated with securities litigation.

Conclusion

With the approaching deadline, it's imperative that institutional holders of BYAH shares evaluate their positions closely. Gathering documentation and initiating contact with legal experts will pave the way for a potentially successful resolution to the investor grievances outlined in the class action. For those interested in proceeding, immediate action is recommended, as this class action presents a valuable opportunity for recovery amidst market volatility.

For further inquiries or to understand recovery options available, institutions can reach out to Joseph E. Levi at Levi Korsinsky LLP or visit the firm’s website for more information.